Patents by Inventor Edward Guilmette

Edward Guilmette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH AAV-MIR-SOD1
    Publication number: 20230340489
    Abstract: The present disclosure provides compositions and methods for treating amyotrophic lateral sclerosis (ALS). Among other things, the present disclosure provides inhibitory nucleic acids that inhibit the expression of genes that cause or are implicated in ALS pathogenesis. The present disclosure further provides recombinant adeno-associated virus (rAAV) vectors comprising inhibitory nucleic acids that inhibit the expression of genes that cause or are implicated in ALS pathogenesis.
    Type: Application
    Filed: September 15, 2021
    Publication date: October 26, 2023
    Inventors: Shih-Ching Lo, Alexander McCampbell, Maria Zavodszky, Edward Guilmette, Barret Pfeiffer
  • Cap for a reaction vessel or the like
    Patent number: D1028279
    Type: Grant
    Filed: June 13, 2022
    Date of Patent: May 21, 2024
    Assignee: CEM Corporation
    Inventors: Timothy Adam Zawatsky, Steven Francis Guilmette, William Edward Jennings, Ian Stuart Goldstein